UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K/A
(AMENDMENT NO. 1)
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): NOVEMBER 26, 2007
-----------------
BIONOVO, INC.
- --------------------------------------------------------------------------------
(Exact Name of Company as Specified in Its Charter)
DELAWARE
- --------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
000-50073 20-5526892
- --------------------------------------------------------------------------------
(Commission File Number) (IRS Employer Identification No.)
5858 HORTON STREET, SUITE 375
EMERYVILLE, CALIFORNIA 94608
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(510) 601-2000
- --------------------------------------------------------------------------------
(Company's Telephone Number, Including Area Code)
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
- --------------------------------------------------------------------------------
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS;
-------------------------------------------------------------------
APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF
---------------------------------------------------------------
CERTAIN OFFICERS.
----------------
The Current Report on Form 8-K filed by Bionovo, Inc. on November 29, 2007
is hereby amended and restated in its entirety to correct an error in the amount
of bonus reported:
"On November 26, 2007, Bionovo, Inc. (the "Company") paid discretionary
bonuses of $100,000 each to Isaac Cohen, the Chairman and Chief Executive
Officer of the Company, and Mary Tagliaferri, the President and Chief Medical
Officer, and a Director of the Company. The discretionary bonuses were each
approved by the Company's Board of Directors, based on the Compensation
Committee's review of their accomplishments and contributions during 2007."
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
BIONOVO, INC.
Date: November 29, 2007 By: /s/ Thomas C. Chesterman
------------------------------
Name: Thomas C. Chesterman
Title: Chief Financial Officer,
Senior Vice President
